Shopping Cart
Remove All
Your shopping cart is currently empty
Lanreotide (BIM 23014) diTFA, a somatostatin analogue, exhibits antineoplastic activity and may be utilized in carcinoid syndrome research [1] [2].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | Lanreotide (BIM 23014) diTFA, a somatostatin analogue, exhibits antineoplastic activity and may be utilized in carcinoid syndrome research [1] [2]. |
| In vitro | Lanreotide (BIM 23014) at 100 nM concentration, increased apoptosis when combined with radiation over a period of 0 to 48 hours [1]. |
| In vivo | Lanreotide administered subcutaneously at dosages ranging from 2.5 to 10 mg/kg daily for five consecutive days leads to the inhibition of tumor growth [1]. |
| Synonyms | BIM 23014 diTFA |
| Molecular Weight | 1324.37 |
| Formula | C58H71F6N11O14S2 |
| Cas No. | 1024499-83-9 |
| Smiles | OC(C(F)(F)F)=O.O=C([C@@H](NC([C@H](CSSC[C@H](NC([C@@H](NC([C@@H](NC1=O)CCCCN)=O)C(C)C)=O)C(N[C@H](C(N)=O)[C@H](O)C)=O)NC([C@H](N)CC2=CC3=C(C=CC=C3)C=C2)=O)=O)CC4=CC=C(C=C4)O)N[C@@H]1CC5=CNC6=CC=CC=C56.OC(C(F)(F)F)=O |
| Sequence Short | {d-2nal}-CY-{d-Trp}-KVCT-NH2 (Disulfide bridge: Cys2-Cys7) |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.